Clinical products
Premium antibodies (GMP)
Intracellular staining
Surface staining
Hematology
Kits
Lysing solutions
Premixed antibody combinations
Single color antibodies
Immunodeficiency
COVID-19 kits
Kits
Lysing solutions
Mitogens
Premixed antibody combinations
Single color antibodies
Reproductive immunology
Kits
Lysing solutions
Premixed antibody combinations
New products
Allergy
Kits
Recombinant allergens
Allergen extracts
Other allergens
Research products
Antibodies
CD and related antigens
Blood group antigens
Premixed antibody combinations
Serum, plasma, and secreted proteins
Cytoskeleton and ECM
Isotype controls
MHC antigens
Nucleus
Other intracellular antigens
Small organic molecules
Tags and labels
Microbiology and virology
Accessory reagents
Annexin binding
DNA-binding probes
Lineage cocktail
Lysing solutions
Recombinant proteins
Recombinant allergens
Animal
Food
House Dust Mite
Mold
Pollen
Venom
Kits
New products
Dry Reagents
About exbio
Company
OEM and Commercial Supplies
Blog
Events and Conferences
Promotions
Inquiries
Technical resources
International distributors
Contact
Jobs
E-mail
*
Password
*
Remember me
Forgotten password
Log in
Register
E-mail
Send request
Log in
Exbio
—
Clinical products
—
Immunodeficiency
—
COVID-19 kits
—
DryFlowEx ACT T Screen Kit
DryFlowEx ACT T Screen Kit
Regulatory status
RUO
Reactivity
Human
Application
FC (QC tested)
Variant
50 tests
ED7705
In stock
1080.00 USD
Variant
0.1 mg
11-261-C100
In stock
1080.00 USD
Contact distributor
Product details
Images
References
Application
FC (QC tested)
Reactivity
Human
Description
DryFlowEx ACT T Screen Kit is designed for flow cytometry screening of activated T cells (ACT T) during virus infection.
Multicolor panel of antibody conjugates CD45/ CD8/ CD4/ PD-1/ HLA-DR/ CD3/ CXCR5/ CD38 dried in a single flow cytometry tube enables immunophenotyping of activated T lymphocyte subsets including a specific population of circulating follicular T helper cells in EDTA-anticoagulated human blood.
Contents
50 single-test tubes (ED7705-1T ACT T Screen Tube); each 5 pcs of single-test tubes are packed with dessicant in moisture-protective aluminum pouches (ED7705-5T ACT T Screen 5T Pack)
1 set of compensation tubes (ED7705-CT ACT T Screen Compensation Tubes Pack)
ED7705-CT1 CD4 FITC
ED7705-CT2 PD-1 (CD279) PE
ED7705-CT3 HLA-DR PerCP-Cy™5.5
ED7705-CT4 CD3 PE-Cy™7
ED7705-CT5 CXCR5 (CD185) APC
ED7705-CT6 CD38 APC-Cy™7
ED7705-CT7 CD45 Pacific Blue™
ED7705-CT8 CD8 Pacific Orange™
Identical fluorochrome-labeled antibodies allow easy and accurate compensation procedure.
Storage and handling
Store at 20-30°C. Protect from moisture.
Exbio licence note
The product is intended For Research Use Only. Diagnostic or therapeutic applications are strictly forbidden. Products shall not be used for resale or transfer to third parties either as a stand-alone product or as a manufacture component of another product without written consent of EXBIO Praha, a.s. EXBIO Praha, a.s. will not be held responsible for patent infringement or any other violations of intellectual property rights that may occur with the use of the products. Orders for all products are accepted subject to the Term and Conditions available at www.exbio.cz. EXBIO, EXBIO Logo, and all other trademarks are property of EXBIO Praha, a.s.
Licence note
Alexa Fluor®, Pacific Blue™ and Pacific Orange™ are registered trademarks of Life Technologies Corporation.
Licence label
This product is provided under an intellectual property license from Life Technologies Corporation. The transfer of this product is conditioned on the buyer using the purchased product solely in research conducted by the buyer, excluding contract research or any fee for service research, and the buyer must not (1) use this product or its components for (a) diagnostic, therapeutic or prophylactic purposes; (b) testing, analysis or screening services, or information in return for compensation on a per-test basis; or (c) manufacturing or quality assurance or quality control, and/or (2) sell or transfer this product or its components for resale, whether or not resold for use in research. For information on purchsing a license to this product for purposes orther than as described above, contact Life Technologies Corporation, 5781 Van Allen Way, Carlsbad, CA 92008 USA or outlicensing@lifetech.com.
Example of the kinetics of frequency of immune cells in a COVID-19 patient that required hospitalization.
Upper panel shows the gating procedure for identification of activated helper/inducer CD4+ T lymphocytes in peripheral whole blood of a patient.
Lower panel shows cell frequency (% of T cells) measured in several time points during the hospitalization of a patient.
Example of the kinetics of frequency of immune cells in a COVID-19 patient that required hospitalization.
Upper panel shows the gating procedure for identification of activated cytotoxic CD8+ T lymphocytes in peripheral whole blood of a patient.
Lower panel shows cell frequency (% of T cells) measured in several time points during the hospitalization of a patient.
Example of the kinetics of frequency of immune cells in a COVID-19 patient that required hospitalization.
Upper panel shows the gating procedure for identification of circulating T helper follicular Cells in peripheral whole blood of a patient.
Lower panel shows cell frequency (% of T cells) measured in several time points during the hospitalization of a patient.
Flow cytometry phenotyping strategy for identification of activated T cells in normal human peripheral whole blood.
1. Singlet cell events
2. Leukocytes
3. Lymphocytes
4. CD3+ T lymphocytes
5. CD4+ vs. CD8+ T lymphocytes
Bottom-middle: activated CD8+ cytotoxic T lymphocytes
Bottom-right: circulating follicular helper T lymphocytes
Top-right: activated CD4+ helper/inducer T lymphocytes
Flow cytometry surface staining pattern of activated cytotoxic CD8+ T lymphocytes (left), activated helper/inducer CD4+ T lymphocytes (middle) and circulating T helper follicular Cells (right) stained using ED7705 DryFlowEx Act T Screen kit in normal human peripheral whole blood.
For each target population the frequency(% of T cells) is shown.
Product specific references:
Klocperk A, Bloomfield M, Páráčková Z, Zentsová I, Vrabcová P, Balko J, Meseznikov G, Casas Mendez LF, Grandcourtová A, Šípek J, Tulach M, Zámečník J, Vymazal T and Šedivá A: Complex immunometabolic profiling reveals the activation of cellular immunity and biliary lesions in patients with severe COVID-19. J. Clin. Med. 2020, 9(9), 3000;doi.org/10.3390/jcm9093000
PubMed
Variant
50 tests
ED7705
In stock
1080.00 USD
Variant
0.1 mg
11-261-C100
In stock
1080.00 USD
Contact distributor
Datasheet download
CS
EN
SDS download
CS
EN
Bulk requests
Technical support for this product
Related products
ED7066
EXCELLYSE Easy
-134%
Clone
Reg. status
CE IVD
Application
FC
100 ml
200.00 USD
ED7704
DryFlowEx ASC Screen Kit
-134%
Clone
Reg. status
RUO
Application
FC
50 tests
1000.00 USD
Continue to checkout
×
Zavřít